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Prostate cancer (PC) is still the second cause of cancer-related death among men. Although patients with metastatic
presentation have an ominous outcome, the vast majority of PCs are diagnosed at an early stage. Nonetheless, even among
patients with clinically localized disease the outcome may vary considerably. Other than androgen sensitivity, little is known
about which other signaling pathways are deranged in aggressive, localized cancers. The elucidation of such pathways may
help to develop innovative therapies aimed at specific molecular targets. We report that in a hormone-sensitive PC cell line,
LNCaP, Notch3 was activated by hypoxia and sustained cell proliferation and colony formation in soft agar. Hypoxia also
modulated cellular cholesterol content and the number and size of lipid rafts, causing a coalescence of small rafts into bigger
clusters; under this experimental condition, Notch3 migrated from the non-raft into the raft compartment where it colocalized
with the c-secretase complex. We also looked at human PC biopsies and found that expression of Notch3 positively correlated
with Gleason score and with expression of carbonic anhydrase IX, a marker of hypoxia. In conclusion, hypoxia triggers the
activation of Notch3, which, in turn, sustains proliferation of PC cells. Notch3 pathway represents a promising target for
adjuvant therapy in patients with PC.
Prostate cancer (PC) represents nearly a quarter of all newly
diagnosed cases of male cancers.1 The majority of PCs are
slow growing; however, there are cases with aggressive
growth and high risk of metastasis. As suggested for many
solid tumors, hypoxia plays an important role in the progres-
sion of PC where low oxygen tension correlates with poor
clinical outcome.2,3 Although conditions of extreme hypoxia
may hamper the ability of tumor cells to survive, milder
hypoxic conditions set off the “hypoxia response” program,
which is orchestrated by the hypoxia-inducible factor (HIF)-
1a, and convey to tumor cells the ability to adapt to the
environment with a survival advantage.4,5
We previously demonstrated that exposure of PC cells to
chronic hypoxia (2% oxygen) resulted in a profound change
of the Notch signaling system with a strong downregulation
of Notch1 and Notch2 mRNA and protein; interestingly, no
significant changes were detected in Notch3 expression.6
Notch signaling controls cell differentiation across a wide
range of cell types,7 during development and in adult tissues,
and mutations of Notch genes are responsible for several dis-
eases, including cancer.8 Such a wide range of effects are
dependent upon an apparently simple mechanism of receptor
activation, where ligand binding results in a proteolytic cleav-
age of the transmembrane receptor protein, first by an
ADAM metalloprotease9 and next by a g-secretase, that
releases an intracellular domain (NICD). NICD translocates
to the nucleus where it interacts with the CBF1/Suppressor of
Hairless/LAG-1 (CSL) family of DNA-binding proteins, lead-
ing to the activation of target genes.8
Although apparently straightforward, the Notch signaling
output is exposed to a meticulous series of check points at dif-
ferent steps of activation.8 One of such checkpoint involves the
g-secretase activity, which is highly sensitive to membrane
composition. Indeed, several lines of evidence have indicated
that the enzyme ability to activate its substrates depends upon
its distribution between raft and nonraft microdomains of the
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plasma membrane, with lipid rafts supporting the highest
enzyme activity.10,11 Hence, to activate the Notch signaling
pathway, g-secretase and Notch receptor need to partition to
the same compartment of plasma membrane. It is likely that a
change of local lipid composition, as it may occur during
hypoxia,12,13 may contribute to control the level of Notch acti-
vation through the modulation of g-secretase function.
We now report that hypoxia modifies cell cholesterol con-
tent and membrane microdomain composition, in vitro, pro-
moting the interaction between Notch3 receptor and g-
secretase. Activation of Notch3 sustains cell proliferation of
PC cells and correlates with malignancy in vitro and tumor
grading in human tissues.
Material and Methods
Antibodies and chemicals
Anti-Notch1 (sc-6014-R), Notch3 (M-134) (sc-5593) and Nicas-
trin (H-300) (sc-25648) antibodies were obtained from Santa
Cruz Biotechnology (DBA, Italy); anti-Notch2 (D67C8) and
GAPDH antibodies were obtained from Cell Signaling Technol-
ogy (EuroClone, Milan, Italy); anti-Presenilin1 (S182) antibody
was obtained from Sigma (Sigma-Aldrich S.r.l., St. Louis, MO);
anti-HIF-1a antibody was obtained from Novus Biologicals
(DBA, Italy) and anti-carbonic anhydrase (CA) IX (M75)
antibodies from Bioscience (Bratislava, Slovakia S.R.O.). Horse-
radish peroxidase (HRP)-conjugated secondary anti-rabbit and
anti-mouse antibodies were purchased from Pierce Biotechnol-
ogy (EuroClone). All other reagents were obtained from Sigma
unless otherwise stated. The g-secretase inhibitor N-[N-(3,5-
difluorophenacetyl)-l-alanyl]-S-phenylglycine t-butyl ester
(DAPT) was dissolved in dimethyl sulfoxide (DMSO) (20mM
stock solution). Puromycin dihydrochloride was obtained from
Santa Cruz Biotechnology.
Cell cultures
The androgen-dependent human PC cell line, LNCaP, and
the androgen-independent cell lines, PC-3 and Du145, were
obtained from ATCC (LGC Standards S.r.l., Sesto San Gio-
vanni, Italy), maintained in liquid nitrogen and used within
few weeks after thawing and plating. Cells were grown in
RPMI-1640 (EuroClone) (LNCaP) and DMEM (PC-3 and
Du145), supplemented with 10% (vol/vol) fetal bovine serum
(FBS) (EuroClone), L-glutamine (EuroClone) and 1% (vol/
vol) antibiotic/antimycotic solution (Gibco, Invitrogen S.r.l.,
San Giuliano Milanese, Italy). Hypoxia was achieved by
maintaining the cells at 2% oxygen, in a CO2 incubator
(Forma Series II, Thermo Scientific, Rodano (MI), Italy) with
oxygen sensor control, and CO2 and N2 gas regulators.
shRNA lentiviral particles transduction
Notch3 shRNA (h) lentiviral particles (sc-37135-V, Santa
Cruz Biotechnology) containing three target-specific con-
structs that encode 19- to 25-nucleotide (plus hairpin)
shRNA were used for the inhibition of Notch3 expression in
LNCaP cells. Control shRNA lentiviral particles (sc-108080,
Santa Cruz Biotechnology), encoding a scrambled shRNA
sequence, were used as negative control. Cells with stable
expression of Notch3 shRNA (siN3) and control shRNA
(scrambled) were isolated by puromycin selection and the
extent of gene knockdown was analyzed by Western blotting.
Analysis of cell growth
Cells were grown for selected times, detached by trypsin and
counted using a hemocytometer. Four wells were counted for
each point. The experiment was repeated thrice. For growth
in soft agar, cells were plated on a 0.5% agar cushion in an
overlay containing RPMI, 10% FBS and 0.33% agar. After 3
weeks, colonies were stained with p-iodonitrotetrazolium vio-
let and counted by naked eye. Four plates were counted for
each condition. The experiment was repeated three times.
Student’s t-test was used for statistical analysis.
Western blotting
For FL-Notch3 detection, cells were lysed in cold buffer
(10mM Tris-HCl, pH 7.4, 25mM MgCl2, 1% Triton X-100,
1mM dithiothreitol, 0.1mM phenylmethylsulfonyl fluoride,
10 lg/ml leupeptin, 2 lg/ml aprotinin and 1mM Na3VO4) and
resolved by 10% sodium dodecyl-sulfate (SDS)-polyacrylamide
gel electrophoresis (PAGE). For detection of Notch3 ICD and
HIF-1a, cells were lysed in cold buffer (20mM HEPES,
0.2mM EDTA, 25% glycerol, 25mM MgCl2, 420mM NaCl,
0.5% NP40, 1mM dithiothreitol, 1mM phenylmethylsulfonyl
fluoride, 10lg/ml leupeptin, 2 lg/ml aprotinin and 1mM
Na3VO4) and resolved by 10% SDS-PAGE. Notch3 immunore-
active bands were visualized by chemioluminescence (ECL)
(GE Healthcare Italia, Euroclone). Densitometric analysis was
performed using GAPDH for normalization.
Cholesterol measurement
The amount of cholesterol was determined by gas chromatog-
raphy/mass spectrometry (GC/MS) as previously described.14
Briefly, cells were lysed in 1 N NaOH and 10 lg of proteins
What’s new?
Hypoxia can play an important role in tumor progression, by altering the expression of a number of regulatory genes. In this
study, the authors found that hypoxia can lead to the activation of Notch3 in prostate cancer (PC) tumor cells, by altering the
membrane structure of these cells. Notch3 expression correlates with tumor grade in human cancers. The Notch signaling
pathway may therefore be a promising target for adjuvant therapy in PC. Immunostaining for Notch3 may also provide a useful
biomarker for identifying tumors with a poor prognosis.
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was used for cholesterol determination. Sterols were extracted
with n-hexane and derivatized in bis-N,O-(trimethylsilyl)-tri-
fluoroacetamide (BSTFA) with 10% trimethylchlorosilane at
70C for 30min. BSTFA solutions (2 ll) were analyzed in a
Hewlett-Packard GC-MS system composed of a 6890 series II
gas chromatograph equipped with a 5973 mass spectrometry
detector, a 6890 automatic injector and a GC column
(J&W DB-1, Agilent, Cemusco sul Naviglio, Italy) (15 m3
0.25mm3 0.25lm). Results (mean6 SE) are expressed as
fold cholesterol variations compared to control. All measure-
ments were carried out in triplicate and the experiment was
performed at least three times. Interassay coefficient of varia-
tion was less than 10% in all the concentration range of the cal-
ibration curve. Student’s t-test was used for statistical analysis.
Immunofluorescence confocal microscopy
To identify lipid rafts, cells were marked with cholera toxin
(CT) b-subunit conjugated with AlexaFluorVR 594 (V-34405
VybrantVR AlexaFluorVR 594 Lipid Raft Labeling Kit, Molecu-
lar Probes, Life Technologies, Monza, Italy), which binds to
the monosialo-tetra-hexosylganglioside (GM1)—a sphingoli-
pid associated with lipid rafts—following the manufacturer’s
instructions. Coverslips were fixed with paraformaldehyde,
mounted with ProLong Gold antifade reagent (InVitrogen,
Life Technologies) and imaged on a TCS SP5 Leica R confo-
cal microscope, equipped for fluorescence measurements.
Maximum fluorescence intensity of each acquired image was
analyzed by using ImageJ 1.44 software (www.rsb.info.nih.-
gov/ij; National Institutes of Health), which was also used for
statistical evaluation of cluster areas, fluorescence intensities
and background signals. Analysis of number and size of lipid
raft clusters was conducted as previously described.15
Isolation of lipid rafts
Isolation of lipid rafts was performed using a Caveolae/Rafts
isolation kit (Sigma), which is based on a density gradient
(OptiPrep) and CT b-subunit conjugated with peroxidase
(CTB-HRP) as raft marker.16 After centrifugation (22 hr at
35,000 rpm at 4C) nine fractions were collected and ana-
lyzed by dot-blot using 5ll of each fraction on a polyvinyli-
dene difluoride (PVDF) membrane (Amersham Pharmacia
Biothec, GE Healthcare Life Sciences, Milan, Italy), using
CTB-HRP and anti-CD 71 (Santa Cruz Biotechnology) anti-
bodies to identify raft (R) and non-raft (NR) fractions,
respectively. Fractions 3-4 (R) and fractions 7-8 (NR) were
then resolved by 8% (w/v) SDS-PAGE, transferred to a
PVDF membrane and immunoblotted using primary anti-
bodies against human Nicastrin (1:750), Presenilin 1
(1:5,000), Notch1 (1:1,000), Notch2 (1:1,000) and Notch3
(1:1,000). Immunoreactive bands were visualized by chemio-
luminescence using a ChemiDoc XRS.
Immunocytochemistry
Cells were grown on poly-L-lysine-treated slides and fixed with
acetone. Immunocytochemistry was performed using the HRP
multimer system (Ultra Vision Quanto Detector System,
Thermo Scientific, Bio-Optica, Milan, Italy) and anti-Notch3
antibodies. 3,30-Diaminobenzidine (DAB; Quanto, Thermo Sci-
entific) was used as chromogen for the development of peroxi-
dase activity (Hydrogen Peroxide Block Kit, Thermo Scientific).
Immunohistochemistry
A total of 170 core needle biopsies and 20 non-neoplastic
specimens were collected at the Urological Division of Siena
University Hospital. The mean age of patients was 70.4 (range
54–86 years); none had received treatment for PC at the time
of biopsy. Informed written consent was obtained. Paraffin
embedded specimens were cut into sections of 4-lm thickness
and stained with hematoxylin/eosin. Tumor grade and score
were established according to the Gleason grading system17 in
each core needle biopsy by an expert pathologist (MTDV).
Tumor sections were classified as low grade when Gleason
score was <7 and as high grade when Gleason score was >8.
Foci of high-grade intraprostatic neoplasia (PIN) were identi-
fied in peritumoral areas. Negative core needle biopsies were
diagnosed as basal cell hyperplasia and atrophy. Staining was
performed on 41 0.5-lm-thick sections of each block using
the Ultravision Detection System Anti-Polyvalent HRP (Ultra
V Block) (LabVision, Fremont, CA, Bio-Optica). Slides were
incubated with anti-Notch1, Notch2 and Notch3 antibodies
(1:50; pH 6) using DAB (DAKO, Milan, Italy) as chromogen.
Sections were weakly counterstained with Harris’ hematoxylin
and examined under a light microscope. Nonimmune serum
immunoglobulins were used as negative controls. A semiquan-
titative measure of immunostaining was obtained using the
HSCORE18 as follows: 1 (weak, but detectable), 2 (moderate)
and 3 (intense). Three different fields (100 cells per field) were
evaluated at 203 objective magnification. The analysis was
performed by two blinded investigators (MRA and BJR) and
the average score was used. Statistical analysis was performed
using SYSTAT-7. The difference in Notch3 expression was
analyzed by chi-square test. To analyze the degree of hypoxia,
18 low-grade and 16 high-grade adenocarcinomas were
stained with anti-CA IX antibodies.19 HSCORE was used as a
semiquantitative measure of immunostaining. Chi-square test
and k statistics were used to determine the existence of a cor-
relate between Notch3 and CA IX expression. In any case, a
p< 0.05 was considered statistically significant.
Results
Notch3 is activated in PC cells under hypoxia
LNCaP cells were exposed to normoxia or hypoxia for 7
days. The expression of HIF-1a protein was enhanced under
reduced oxygen tension (Fig. 1b). Expression of transmem-
brane full-length (FL) Notch3 was strong under normoxia
(N) (Fig. 1a) but almost undetectable under hypoxia (H).
However, the drop of FL Notch3 at low oxygen was lessened
by treatment with the g-secretase inhibitor DAPT (H 1 D),
suggesting that Notch3 was strongly activated under hypoxic
conditions. Treatment with DAPT also resulted in an
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increase, although less striking, of FL Notch3 under nor-
moxia (N 1 D), indicating some degree of receptor activity.
To verify that activation of Notch3 was potentiated under
hypoxia, we looked at Notch3 intracellular domain (N3
ICD). As shown in Figure 1b, the amount of N3 ICD
detected at low oxygen was increased compared to normoxia.
To confirm these observations, the expression of Notch3
was assessed by immunocytochemistry (Fig. 1c): under nor-
moxia a mild cytoplasmic staining was present; under hypoxia
Notch3 stain became stronger and mostly nuclear. These data
indicate that receptor activity is high at low oxygen.
Notch3 sustains proliferation of PC cells
To establish the biological role of Notch3 in PC cells, the
Notch3 gene was silenced by stable infection using a
retroviral plasmid. As shown in Figures 2a and 2b, the
amount of Notch3 protein was significantly reduced in
silenced LNCaP cells (siN3) compared to scrambled shRNA
control cells. When we analyzed LNCaP proliferative capacity
under anchorage-dependent and -independent conditions we
found that hypoxia increased the ability of scrambled shRNA
(control) cells to grow and to form colonies in soft agar com-
pared to normoxia (Figs. 2c and 2d). However, siN3 cells
exhibited a significantly hampered capacity to grow both
under normoxia and hypoxia (Figs. 2c and 2d). These data
suggest that activation of Notch3 may sustain LNCaP cells
proliferation.
Hypoxia induces a change of membrane microdomain
composition
Because the ability of g-secretase to activate its substrates
depends upon its distribution between raft and nonraft
microdomains,10,11 a change of membrane microdomain
composition may contribute to control the level of Notch
activity under hypoxia. Because cholesterol is the main com-
ponent of lipid rafts, we studied the effect of hypoxia on cel-
lular cholesterol content by GC/MS. Cholesterol increased
very rapidly (within 12 hr) when the cells were exposed to
2% oxygen and then quickly decreased to normal or below
normal levels; the amount of cholesterol was still below con-
trol cells after 7 days of hypoxia (Fig. 3a).
We next analyzed whether the hypoxia-induced choles-
terol change resulted in a change in lipid raft composition by
confocal microscopy. For this purpose, we analyzed and
counted decorated particles that appeared larger than 1lm2
on the plasma membrane and considered them as “raft
clusters.” The cutoff of 1lm2 was chosen to focus on the
phenomenon of lipid raft “coalescence,” which is responsible
for the formation of large liquid-ordered domains that are
able to compartmentalize an elevated number of proteins
and, in most cases, to favor their activation.15 The maximum
area of clusters and the mean and maximum fluorescence
intensity were also recorded. As shown in Figure 3b, the
number of lipid raft clusters increased within the first 48 hr
of exposure to hypoxia. However, after 7 days the number of
clusters had fallen below the level of normoxic cells. Never-
theless, their area remained significantly increased, likely
owing to the coalescence of small raft microdomains into
bigger clusters.
Hypoxia triggers the colocalization of Notch3 and
c-secretase into lipid rafts
Finally, we sought to determine whether the hypoxia-induced
change of membrane microdomain composition resulted in a
change of Notch3 localization (Fig. 4). Non-raft (NR) and
raft (R) fractions of plasma membranes were isolated from
LNCaP cells grown under normoxia and hypoxia. NR frac-
tions were identified by positivity to CD 71, whereas R frac-
tions were detected through the presence of GM1, using the
CT b subunit (Fig. 4a). Two components of the g-secretase
Figure 1. Expression of Notch3 in PC cells exposed to normoxia
and hypoxia. (a) Total cell lysates from cells exposed to normoxia
(N), normoxia 1 20 lM DAPT (N 1 D), hypoxia (H) or hypoxia 1
20 lM DAPT (H 1 D) for 7 days were analyzed by Western blotting
using anti-Notch3-specific antibody. FL N3: full-length Notch3;
GAPDH indicates normalization of protein loading. (b) Total cell
lysates from cells exposed to normoxia (N) or hypoxia (H) for 7
days were analyzed by Western blotting using anti-Notch3- and
anti-HIF1a-specific antibodies. TM N3: transmembrane Notch3; N3
ICD: Notch3 intracellular domain. GAPDH indicates normalization of
protein loading. (c) Notch3 immunostaining of PC cells exposed to
normoxia or hypoxia for 7 days. [Color figure can be viewed in the
online issue, which is available at wileyonlinelibrary.com.]
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complex, Nicastrin and Presenilin 1, were also detected by
Western blotting (Fig. 4b). Although Nicastrin was always
identified in lipid rafts, Presenilin 1 was present in R and NR
microdomains, under both experimental conditions. How-
ever, although R fractions under normoxia contained the
inactive (degraded) form (18 kDa) of Presenilin 1, R fractions
isolated from hypoxic cells enclosed the FL (48 kDa), active
form of Presenilin 1. As expected, under normoxia Notch1–3
were detected exclusively in the NR compartment.
However, although Notch1 and Notch2 became almost unde-
tectable under hypoxia, Notch3 partially migrated into lipid
rafts, likely becoming a substrate for g-secretase activity
(Fig. 4b).
Expression of Notch3 in human PC cell lines and human
biopsies correlates with aggressiveness and tumor grading
Because Notch3 is activated during hypoxia and hypoxia cor-
relates with tumor aggressiveness, we sought to determine
whether Notch3 expression was related to malignancy in PC
cell lines and human biopsies. Three cell lines of different
malignancy were compared by qPCR for Notch3 expression.
As demonstrated in Figure 5, transcription of Notch3 was
significantly higher in the more malignant cell lines, PC-3
and DU145, compared to the less aggressive, hormone-
dependent, LNCaP cells.
The expression of Notch3 was studied also in 94 low-
grade and 56 high-grade adenocarcinomas and 20 controls
(12 atrophy and eight basal cell hyperplasia) (Fig. 6). A
Notch3 cytoplasmic stain was present in five of 12 biopsies
with atrophy (HSCORE 1) and absent in all cases of basal
cell hyperplasia (data not shown). Notch3 staining was also
detected in six of 11 high-grade PIN, adjacent to neoplastic
glands (HSCORE 1) (Figs. 6c and 6d). Higher Notch3 expres-
sion (HSCORE 3) was observed more frequently in high
Gleason grade (>4; 95%) compared to low Gleason grade
(<3; 22%) (v25 124.330; p< 0.001) (Figs. 6e–6j). A higher
Notch3 immunostaining (HSCORE 3) occurred more fre-
quently in tumors with higher Gleason score (>8; 95%)
Figure 2. Analysis of anchorage-dependent and -independent growth of Notch3-silenced (siN3) PC cells exposed to normoxia and
hypoxia. (a) Expression of full-length (FL) and cleaved (transmembrane, TM) Notch3 in cells transduced with scrambled siRNA and
Notch3 siRNA (siN3). GAPDH indicates normalization of protein loading. (b) Densitometric analysis of FL Notch3 immunoreactive bands
detected in three different N3 siRNA clones (siN3) and scrambled siRNA cells, normalized to GAPDH. The amount of Notch3 protein in
control cells is equal 1. (c) Growth curve of scrambled siRNA and siN3 cells exposed to normoxia (N) and hypoxia (H). Hypoxia
significantly increases, while silencing of Notch3 decreases, the proliferation rate of PC cells. Statistical analysis: **p<0.05 H vs. N in
scrambled siRNA cells; *p<0.0001 siN3 vs. scrambled siRNA cells, under H; §p<0.01 siN3 vs. scrambled siRNA cells, under N. (d) Colony
formation in soft agar of scrambled siRNA (white columns) and siN3 (black columns) cells exposed to normoxia (N) and hypoxia (H) for 3
weeks. Hypoxia significantly increases, while silencing of Notch3 decreases, the ability of PC cells to form colonies. Statistical analysis:
**p<0.03, H vs. N in scrambled siRNA cells; *p<0.004, siN3 vs. scrambled siRNA cells, under N; §p<0.01, siN3 vs. scrambled siRNA
cells, under H.
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compared to lower Gleason score (<7; 40%) (v25 43.281; p
< 0.001) (Table 1). Remarkably, high-grade tumors showed
Notch3 nuclear staining more often (90%) than low-grade
tumors (7%) (p< 0.001) (Figs. 6e–6j). These data suggest
progression of Notch3 receptor expression and activation
with tumor malignancy. Expression of Notch1 and Notch2
was studied in a subset of 33 needle biopsies where primary
and secondary Gleason grade were analyzed separately (10
Gleason grade 3, 22 Gleason grade 4 and 11 Gleason grade
5). Notch1 was expressed in 80% of Gleason grade 3, with
60% showing a HSCORE 1. Only two cases of Gleason grade
4 (9%) showed Notch1 positivity, with a HSCORE 1. None
of the Gleason grade 5 was Notch1 positive (data not
shown). Notch2 staining was observed in 20% of Gleason
grade 3 and in 4.5% of Gleason grade 4, with a HSCORE 1.
None of the Gleason grade 5 was Notch2 positive (data not
shown). In any case, Notch1 and Notch2 staining was con-
fined to the cytoplasm.
Carbonic anhydrase IX was detected as a marker of
hypoxia20 (Fig. 7). In low-grade adenocarcinomas, CA IX
stain was mainly observed in the cytoplasm of the neoplastic
cells and in scattered nuclei, with an HSCORE 1 (27%) or 2
(72%). In high-grade carcinomas, CA IX was expressed
in the cytoplasm and in the nucleus of the neoplastic cell
with strong intensity, with 87.5% of samples showing a
HSCORE 3. Statistical analysis demonstrated a significant,
direct correlation between CA IX and Notch3 expression
(p< 0.0001).
Discussion
PC is mostly diagnosed at an early stage.21 However, even
among patients with clinically localized disease, the outcome
may vary depending on several biochemical and clinical
parameters, with Gleason grade being the most potent pre-
dictor of mortality.22 However, there is still insufficient infor-
mation as to which signaling pathways are deranged in
Figure 3. Analysis of cholesterol level and lipid raft composition of PC cells exposed to normoxia and hypoxia. (a) Amount of total cell cho-
lesterol detected in cells maintained under normoxia (N) or exposed to hypoxia (H) for 12 hr, 24 hr and 7 days. Statistical analysis:
*p<0.003, H 12 hr vs. N; §p<0.001, H 24 hr and 7 days vs. N. (b) Fluorescence analysis for the assessment the number/size of raft clus-
ters. Data are based on the analysis of rearrangement of membrane rafts and are obtained by pooling data from each single cell. Control
data are presented as raw data obtained by ImageJ analysis of a wide pool of control cells. Other data are presented as percentage
changes compared to control. The second column reports the percentage change in the area of labeled contiguous structures that is taken
as a measure of raft clusterization. Rafts for each cell were obtained by isolating high fluorescent spots, restricting the fluorescent spot by
size, and processing data with the “Analyze Particle” command contained in ImageJ 1.44 software. [Color figure can be viewed in the online
issue, which is available at wileyonlinelibrary.com.]
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aggressive, clinically localized PC. Identification of those
pathways may result in the design of innovative therapies
aimed at specific molecular targets.
It is well established that solid tumors are exposed to both
acute and chronic hypoxia,23 and that hypoxia is an inde-
pendent prognostic predictor of poor clinical outcome.24 In
patients with localized disease, a study of intraprostatic oxy-
gen tension demonstrated the presence of pronounced
hypoxia with a significant heterogeneity in oxygenation inside
different areas of the tumors.25 In LNCaP cells, chronic
hypoxia induces androgen-independent growth and
establishes a more aggressive phenotype.26 We demonstrated
previously that when LNCaP cells are exposed to chronic
hypoxia, Notch1 and Notch2 mRNA and protein are mark-
edly reduced, as well as the transcription of the canonical
Notch target genes, HES1 and HEY1.6 We now report that,
under the same experimental conditions, Notch3 expression
is preserved and the receptor appears to be more active com-
pared to normoxia. We also showed that Notch3 was able to
sustain the growth of cancer cells, as demonstrated by the
inhibitory effect of Notch3 silencing on cell proliferation.
Taken together, these data suggest that Notch3 may remain
the only active receptor at low oxygen and, therefore, its
function may become critical for the proliferative capacity of
PC cells under hypoxia.
Notch signaling is linked to cancer and hypoxia at several
levels. Hypoxia maintains stem/precursors cells in an undif-
ferentiated state in a Notch-dependent manner.27 Hypoxia
also induces epithelial-mesenchymal transition (EMT) in a
Notch-dependent manner and Notch inhibition abrogates
EMT and cell invasion in different tumor types.28 In a mouse
model of pulmonary arterial hypertension, low oxygen upre-
gulates the expression of Notch3.29
The hypoxia-induced activation of Notch3 in LNCaP
cells is likely to be driven by the change of membrane
microdomain conformation that we observed by confocal
microscopy. The method we used to analyze lipid raft dis-
tribution was developed by our group and previously used
for the study of caveolar rafts.15 Here, the same method
was applied to the analysis of planar rafts and it allowed us
to quantify the macrophenomenon of raft clusterization that
may be linked to Notch3 activation. We propose that,
under hypoxia, Notch3 receptor translocates from the non-
raft to the raft portion of the plasma membrane where the
g-secretase complex resides in its active state. Therefore,
Notch3 may become the natural substrate of the enzyme,
which cleaves the receptor leading to the nuclear transloca-
tion of NICD.
Recently, gene expression profile of Gleason low-grade
and high-grade tumors was obtained30 and 670 genes were
found to be differentially expressed. Among them, Notch and
epidermal growth factor receptor (EGFR) signal transduction
pathways appeared to be upregulated in high-grade, localized
PC. A potential cross-talk between Notch and EGFR is of
particular interest in light of the recent report that a syner-
gism between Notch3 and EGFR/MAPK pathway supports
the pathogenesis of lung cancer.31 In a study by Long et al.,32
the RNA from 70 radical prostatectomy specimens of known
outcome was isolated for gene expression profiling: Notch3
gene was among the ten protein-coding genes that were able
to identify patients with recurrence. In our study, we went
beyond gene expression and found that the level of Notch3
receptor protein significantly correlated with Gleason grade
in human PC biopsies. We also found that Notch3 staining
was mainly nuclear in high-grade tumors, suggesting receptor
activation. Moreover, staining for CA IX, a downstream
Figure 4. Distribution of g-secretase components and Notch1–3
receptors in raft and non-raft compartments of plasma membrane
in PC cells exposed to normoxia and hypoxia. (a) Dot-blot for the
characterization of raft (R) and non-raft (NR) compartments of
plasma membrane obtained from PC cells grown under normoxia
(N) and hypoxia (H) for 7 days. R fractions are identified for their
positivity to CT-b subunit; NR fractions are identified for their posi-
tivity to CD 71. Fractions 3-4 and fractions 7-8 were chosen for fur-
ther characterization. (b) Western blotting of fractions 3-4 (R) and
7-8 (NR) for detection of Nicastrin, Presenilin1, Notch1, Notch2
and Notch3. The inactive (18 kDa) and active (48 kDa) forms of
Presenilin1 are indicated. The asterisk underlines the colocalization
of Nicastrin, active Presenilin1 and Notch3 into the R compartment
under hypoxia.
Figure 5. Notch3 mRNA expression in LNCaP, PC-3 and Du145
cells, assessed by quantitative real-time PCR. Data are expressed
as Dct. *p<0.05, PC-3 and Du145 vs. LNCaP.
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target of HIF-1a33 and a marker of hypoxia,20 showed that
there was a significant, direct correlation of Notch3 expres-
sion with reduced oxygen tension.
Finally, the level of expression of Notch3 mRNA well cor-
related with the degree of malignancy of different PC
cell lines, supporting a role of the receptor in disease
progression.
It has been demonstrated previously that Notch1 knock-
down causes growth inhibition and S-phase arrest of PC
cells.34 Moreover, activation of Notch1 signaling appears to
sustain motility and migration of cancer cells.35 We propose
that when oxygen tension decreases inside the tumor mass,
Notch3 becomes the main Notch receptor to be transcribed
and to sustain the growth of malignant cells.
In conclusion, Notch signaling pathway may represent a
good molecular target for adjuvant therapy in patients with
Figure 6. Expression of Notch3 in non-malignant and malignant prostate biopsies assessed by immunohistochemistry. (a and b) Mild cyto-
plasmic staining in normal prostatic gland; (c and d) mild cytoplasmic staining in high-grade PIN, more intense at the apical pole of glandu-
lar cells; (e and f) moderate cytoplasmic staining in Gleason grade 3 PC; (g–j) strong cytoplasmic and nuclear staining in Gleason grade 4
(g and h) and Gleason grade 5 (i and j) PC. Original magnification: a–d, 3400; e–j, 3200. [Color figure can be viewed in the online issue,
which is available at wileyonlinelibrary.com.]
Table 1. Correlation between Notch3 and Gleason classification of
human PC biopsies
Gleason grade
HSCORE 3 (n) 4 (n) Total (n)
1 45 0 45
2 23 6 29
3 20 121 141
Total (n) 88 127 215
Gleason score
HSCORE 7 (n) 8 (n) Total (n)
1 40 0 40
2 15 3 18
3 39 53 92
Total (n) 94 56 150
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PC. However, we need to learn more about the differential
roles of Notch receptors and their modulation during the
development and progression of PC in order to obtain the
maximal benefit from a Notch-targeted therapy. Finally,
Notch3 immunostaining of localized PC biopsies may
increase our ability to identify tumors with severe prognosis
that may require a more aggressive therapy.
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